Immunology
Latest News
FDA issues letter regarding lebrikizumab review for atopic dermatitis
The agency cited concerns related to an inspection of a third-party contract manufacturer.
Latest News
Study finds inflammatory bowel disease risk higher in children, adults with atopic dermatitis
AD has been associated with an increasing number of comorbidities, including IBD, but studies linking AD with IBD have had mixed results,...
From the Journals
Many young people stop ulcerative colitis maintenance treatment, risking relapse
Globally, the incidence of UC is increasing fastest in younger populations. It’s estimated that up to 30% of individuals with UC are diagnosed in...
Feature
Are ketogenic supplements the key to healthy aging?
Drawbacks of the initial formulations of ketone esters, first developed 20 years ago, included high cost and terrible taste.
From the Journals
People with long COVID have specific blood biomarkers, study says
The findings may be a step toward creating blood tests to positively identify people with long COVID so specialized treatments can be employed.
Conference Coverage
Patients with rheumatism have premature immune system aging
Researchers have studied how the T-cell aging process translates into metabolic reprogramming of the T cells in patients with rheumatoid arthritis...
Latest News
Primary care clinicians should spearhead HIV prevention
U.S. Preventive Services Task Force guidelines call for clinicians to prescribe pre-exposure prophylaxis drugs to adolescents and adults who do...
Latest News
Company submits supplemental NDA for topical atopic dermatitis treatment
The development is based on results from two identical phase 3, vehicle-controlled trials.
Latest News
Expunging ‘penicillin allergy’: Your questions answered
Great to hear the enthusiasm for testing for penicillin allergy!
Conference Coverage
‘Exciting’ results for cancer vaccine plus pembro in melanoma
A new randomized study is the first to demonstrate improvement in recurrence-free survival in melanoma with an individualized neoantigen vaccine...
Commentary
Don’t fear testing for, and delabeling, penicillin allergy
Sometimes, we have to take the most expedient action in health care. But most of the time, we should do the right thing, even if it’s harder.